Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis

Barbara A. Eberhard, M. Cristina Sison, Beth S. Gottlieb, Norman Todd Ilowite

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Objective. To compare patients with juvenile rheumatoid arthritis (JRA) injected with triamcinolone hexacetonide (TH) or triamcinolone acetonide (TA) with respect to time to relapse. Methods. This was a retrospective chart review of 85 patients: 51 patients with JRA who had received a joint injection with TH during the period June 2000-April 2001 and 48 patients who had received a joint injection with TA during the period May 2001-March 2002 who were followed for a minimum of 15 months, after an intraarticular steroid injection. Results. The primary endpoint variable for the study was the time to relapse of the arthritis in the affected joint following an intraarticular injection. A total of 227 joints were injected, 114 with TH and 113 with TA. In the TH group the mean time to relapse (± SE) was 10.14 ± 0.49 months compared to the TA group at 7.75 ± 0.49 months (p < 0.0001) using the log-rank test. A proportional hazards (Cox) regression analysis revealed no statistical association between sex, duration of illness, or type of arthritis and relapse time. An analysis was performed on the first intraarticular injection for each patient, with the average time to relapse for all joints injected of 10.36 ± 0.72 months for TH compared to 8.45 ± 0.78 months for TA (p < 0.02). A further analysis of the first knee injections showed a relapse time in the TH group of 11.11 ± 0.81 months compared to 7.95 ± 0.95 months for TA (p < 0.008). Conclusion. TH offers an advantage to TA, as there is a longer duration of action leading to an improved prolonged response rate in weight-bearing joints, particularly the knees. The results suggest that TH should be the intraarticular steroid of choice, particularly for the knee joint, in patients with JRA.

Original languageEnglish (US)
Pages (from-to)2507-2512
Number of pages6
JournalJournal of Rheumatology
Volume31
Issue number12
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Triamcinolone Acetonide
Juvenile Arthritis
Recurrence
Intra-Articular Injections
Joints
Therapeutics
Knee Joint
Injections
Arthritis
Steroids
triamcinolone hexacetonide
Weight-Bearing
Knee
Regression Analysis

Keywords

  • Arthritis
  • Childhood
  • Intraarticular steroids
  • Treatment

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. / Eberhard, Barbara A.; Sison, M. Cristina; Gottlieb, Beth S.; Ilowite, Norman Todd.

In: Journal of Rheumatology, Vol. 31, No. 12, 12.2004, p. 2507-2512.

Research output: Contribution to journalArticle

@article{6f3c9db1a6254e12888ec66f7acc79f1,
title = "Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis",
abstract = "Objective. To compare patients with juvenile rheumatoid arthritis (JRA) injected with triamcinolone hexacetonide (TH) or triamcinolone acetonide (TA) with respect to time to relapse. Methods. This was a retrospective chart review of 85 patients: 51 patients with JRA who had received a joint injection with TH during the period June 2000-April 2001 and 48 patients who had received a joint injection with TA during the period May 2001-March 2002 who were followed for a minimum of 15 months, after an intraarticular steroid injection. Results. The primary endpoint variable for the study was the time to relapse of the arthritis in the affected joint following an intraarticular injection. A total of 227 joints were injected, 114 with TH and 113 with TA. In the TH group the mean time to relapse (± SE) was 10.14 ± 0.49 months compared to the TA group at 7.75 ± 0.49 months (p < 0.0001) using the log-rank test. A proportional hazards (Cox) regression analysis revealed no statistical association between sex, duration of illness, or type of arthritis and relapse time. An analysis was performed on the first intraarticular injection for each patient, with the average time to relapse for all joints injected of 10.36 ± 0.72 months for TH compared to 8.45 ± 0.78 months for TA (p < 0.02). A further analysis of the first knee injections showed a relapse time in the TH group of 11.11 ± 0.81 months compared to 7.95 ± 0.95 months for TA (p < 0.008). Conclusion. TH offers an advantage to TA, as there is a longer duration of action leading to an improved prolonged response rate in weight-bearing joints, particularly the knees. The results suggest that TH should be the intraarticular steroid of choice, particularly for the knee joint, in patients with JRA.",
keywords = "Arthritis, Childhood, Intraarticular steroids, Treatment",
author = "Eberhard, {Barbara A.} and Sison, {M. Cristina} and Gottlieb, {Beth S.} and Ilowite, {Norman Todd}",
year = "2004",
month = "12",
language = "English (US)",
volume = "31",
pages = "2507--2512",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "12",

}

TY - JOUR

T1 - Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis

AU - Eberhard, Barbara A.

AU - Sison, M. Cristina

AU - Gottlieb, Beth S.

AU - Ilowite, Norman Todd

PY - 2004/12

Y1 - 2004/12

N2 - Objective. To compare patients with juvenile rheumatoid arthritis (JRA) injected with triamcinolone hexacetonide (TH) or triamcinolone acetonide (TA) with respect to time to relapse. Methods. This was a retrospective chart review of 85 patients: 51 patients with JRA who had received a joint injection with TH during the period June 2000-April 2001 and 48 patients who had received a joint injection with TA during the period May 2001-March 2002 who were followed for a minimum of 15 months, after an intraarticular steroid injection. Results. The primary endpoint variable for the study was the time to relapse of the arthritis in the affected joint following an intraarticular injection. A total of 227 joints were injected, 114 with TH and 113 with TA. In the TH group the mean time to relapse (± SE) was 10.14 ± 0.49 months compared to the TA group at 7.75 ± 0.49 months (p < 0.0001) using the log-rank test. A proportional hazards (Cox) regression analysis revealed no statistical association between sex, duration of illness, or type of arthritis and relapse time. An analysis was performed on the first intraarticular injection for each patient, with the average time to relapse for all joints injected of 10.36 ± 0.72 months for TH compared to 8.45 ± 0.78 months for TA (p < 0.02). A further analysis of the first knee injections showed a relapse time in the TH group of 11.11 ± 0.81 months compared to 7.95 ± 0.95 months for TA (p < 0.008). Conclusion. TH offers an advantage to TA, as there is a longer duration of action leading to an improved prolonged response rate in weight-bearing joints, particularly the knees. The results suggest that TH should be the intraarticular steroid of choice, particularly for the knee joint, in patients with JRA.

AB - Objective. To compare patients with juvenile rheumatoid arthritis (JRA) injected with triamcinolone hexacetonide (TH) or triamcinolone acetonide (TA) with respect to time to relapse. Methods. This was a retrospective chart review of 85 patients: 51 patients with JRA who had received a joint injection with TH during the period June 2000-April 2001 and 48 patients who had received a joint injection with TA during the period May 2001-March 2002 who were followed for a minimum of 15 months, after an intraarticular steroid injection. Results. The primary endpoint variable for the study was the time to relapse of the arthritis in the affected joint following an intraarticular injection. A total of 227 joints were injected, 114 with TH and 113 with TA. In the TH group the mean time to relapse (± SE) was 10.14 ± 0.49 months compared to the TA group at 7.75 ± 0.49 months (p < 0.0001) using the log-rank test. A proportional hazards (Cox) regression analysis revealed no statistical association between sex, duration of illness, or type of arthritis and relapse time. An analysis was performed on the first intraarticular injection for each patient, with the average time to relapse for all joints injected of 10.36 ± 0.72 months for TH compared to 8.45 ± 0.78 months for TA (p < 0.02). A further analysis of the first knee injections showed a relapse time in the TH group of 11.11 ± 0.81 months compared to 7.95 ± 0.95 months for TA (p < 0.008). Conclusion. TH offers an advantage to TA, as there is a longer duration of action leading to an improved prolonged response rate in weight-bearing joints, particularly the knees. The results suggest that TH should be the intraarticular steroid of choice, particularly for the knee joint, in patients with JRA.

KW - Arthritis

KW - Childhood

KW - Intraarticular steroids

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=10044225800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044225800&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 2507

EP - 2512

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 12

ER -